Audrey Hémadou

Solid Lipid Nanoparticles for Image-Guided Therapy of Atherosclerosis.

P. Barthélémy, S. Mornet, Khalid Oumzil, 2016, Bioconjugate chemistry.

A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis

M. Duttine, S. Mornet, Audrey Hémadou, 2021, International journal of molecular sciences.

An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosis

Ségolène Antoine, S. Claverol, Audrey Hémadou, 2018, Scientific Reports.

Pacific Biosciences Sequencing and IMGT/HighV-QUEST Analysis of Full-Length Single Chain Fragment Variable from an In Vivo Selected Phage-Display Combinatorial Library

J. Korlach, C. Heiner, V. Giudicelli, 2017, Front. Immunol..

Multimodal molecular imaging of atherosclerosis: Nanoparticles functionalized with scFv fragments of an anti-αIIbβ3 antibody.

C. Di Primo, S. Mornet, C. Lorenzato, 2019, Nanomedicine : nanotechnology, biology, and medicine.

A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting

Audrey Hémadou, Marie-Josée Jacobin-Valat, G. Clofent-Sanchez, 2017, PloS one.

Glioblastoma Immune Landscape and the Potential of New Immunotherapies

M. Saleh, Audrey Hémadou, T. Daubon, 2020, Frontiers in Immunology.

In Vivo Human Single‐Chain Fragment Variable Phage Display‐Assisted Identification of Galectin‐3 as a New Biomarker of Atherosclerosis

E. Ducasse, S. Claverol, C. Lorenzato, 2021, Journal of the American Heart Association.

Development of anti-chloro 192 tyrosine HDL apoA-I antibodies for the immunodiagnosis of cardiovascular diseases.

M. Vijayalakshmi, Audrey Hémadou, Marie-Josée Jacobin-Valat, 2019, Journal of immunological methods.